Product Information
CLOPIDOGREL 300 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $9.2210 per EA under NDC 69367019430. Its NADAC has been published 61 times since Mar 19, 2025.
Strength
300 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367019430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA204165On Market Since
7/27/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOPIDOGREL 300 MG TABLET has been published 61 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2210 per EA |
|---|---|
| All-time high | $9.2210 (May 13, 2026) |
| All-time low | $9.2210 (Mar 19, 2025) |
| 52-week high | $9.2210 |
| 52-week low | $9.2210 |
| Median price | $9.2210 |
| Average price | $9.2210 |
| Largest weekly change | 0.0% (Mar 26, 2025) |
| Weeks tracked | 61 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOPIDOGREL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOPIDOGREL 300 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $9.2210 per EA (NDC 69367019430), effective May 13, 2026.
How has the price of CLOPIDOGREL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOPIDOGREL 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 61 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for CLOPIDOGREL 300 MG TABLET?
Since Mar 19, 2025, the NADAC for CLOPIDOGREL 300 MG TABLET has ranged from a low of $9.2210 (Mar 19, 2025) to a high of $9.2210 (May 13, 2026), with a median of $9.2210 per EA.
Are there cheaper alternatives to CLOPIDOGREL 300 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CLOPIDOGREL 300 MG TABLET, but none are currently priced below it.
Who manufactures CLOPIDOGREL 300 MG TABLET?
CLOPIDOGREL 300 MG TABLET (NDC 69367019430) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification